Study of Dipole Resonance Strength in 12-C via the Reactions 12-C(pol.p,p'c)

This research was sponsored by the National Science Foundation Grant NSF PHY-931478

Reichenbach's Common Cause Principle in Algebraic Quantum Field Theory with Locally Finite Degrees of Freedom

In the paper it will be shown that Reichenbach's Weak Common Cause Principle is not valid in algebraic quantum field theory with locally finite degrees of freedom in general. Namely, for any pair of projections A and B supported in spacelike separated double cones O(a) and O(b), respectively, a correlating state can be given for which there is no nontrivial common cause (system) located in the union of the backward light cones of O(a) and O(b) and commuting with the both A and B. Since noncommuting common cause solutions are presented in these states the abandonment of commutativity can modulate this result: noncommutative Common Cause Principles might survive in these models

Randomized multicentre pilot study of sacubitril/valsartan versus irbesartan in patients with chronic kidney disease: United Kingdom Heart and Renal Protection (HARP)- III—rationale, trial design and baseline data

BACKGROUND: Patients with chronic kidney disease (CKD) are at risk of progression to end-stage renal disease and cardiovascular disease. Data from other populations and animal experiments suggest that neprilysin inhibition (which augments the natriuretic peptide system) may reduce these risks, but clinical trials among patients with CKD are required to test this hypothesis. METHODS: UK Heart and Renal Protection III (HARP-III) is a multicentre, double-blind, randomized controlled trial comparing sacubitril/valsartan 97/103 mg two times daily (an angiotensin receptor-neprilysin inhibitor) with irbesartan 300 mg one time daily among 414 patients with CKD. Patients ≥18 years of age with an estimated glomerular filtration rate (eGFR) of ≥45 but <60 mL/min/1.73 m2 and urine albumin:creatinine ratio (uACR) >20 mg/mmol or eGFR ≥20 but <45 mL/min/1.73 m2 (regardless of uACR) were invited to be screened. Following a 4- to 7-week pre-randomization single-blind placebo run-in phase (during which any current renin-angiotensin system inhibitors were stopped), willing and eligible participants were randomly assigned either sacubitril/valsartan or irbesartan and followed-up for 12 months. The primary aim was to compare the effects of sacubitril/valsartan and irbesartan on measured GFR after 12 months of therapy. Important secondary outcomes include effects on albuminuria, change in eGFR over time and the safety and tolerability of sacubitril/valsartan in CKD. RESULTS: Between November 2014 and January 2016, 620 patients attended a screening visit and 566 (91%) entered the pre-randomization run-in phase. Of these, 414 (73%) participants were randomized (mean age 63 years; 72% male). The mean eGFR was 34.0 mL/min/1.73 m2 and the median uACR was 58.5 mg/mmol. CONCLUSIONS: UK HARP-III will provide important information on the short-term effects of sacubitril/valsartan on renal function, tolerability and safety among patients with CKD

Isospin Response of the 4-He Continuum

This research was sponsored by the National Science Foundation Grant NSF PHY-931478

πNN\pi NN and πNΔ\pi N\Delta formfactors determined from a microscopic model for πN\pi N scattering

We determine the $\pi NN$ and $\pi N\Delta$ formfactors from the $P_{11}$ resp. $P_{33}$ partial wave of $\pi N$ scattering by dressing corresponding bare vertices with the help of $\pi N$ non--pole contributions. The underlying model is based on meson exchange, and involves nucleon and delta--isobar pole and crossed--pole terms together with correlated $\pi\pi$--exchange in the $J^P=0^+$ ($\sigma$) and $1^-$ ($\rho$) channel. The results are very similar for $\pi NN$ and $\pi N\Delta$ and can be roughly parametrized by a monopole with cutoff mass $>$ 500 MeV, with some variation due to model dependencies. Thus the formfactors are much less soft than derived before for the $\pi NN$ case by Saito and Afnan using the same procedure but different $\pi N$ interaction models.Comment: 7 pages, 4 postscript figure

Onset of Superfluidity in 4He Films Adsorbed on Disordered Substrates

We have studied 4He films adsorbed in two porous glasses, aerogel and Vycor, using high precision torsional oscillator and DC calorimetry techniques. Our investigation focused on the onset of superfluidity at low temperatures as the 4He coverage is increased. Torsional oscillator measurements of the 4He-aerogel system were used to determine the superfluid density of films with transition temperatures as low as 20 mK. Heat capacity measurements of the 4He-Vycor system probed the excitation spectrum of both non-superfluid and superfluid films for temperatures down to 10 mK. Both sets of measurements suggest that the critical coverage for the onset of superfluidity corresponds to a mobility edge in the chemical potential, so that the onset transition is the bosonic analog of a superconductor-insulator transition. The superfluid density measurements, however, are not in agreement with the scaling theory of an onset transition from a gapless, Bose glass phase to a superfluid. The heat capacity measurements show that the non-superfluid phase is better characterized as an insulator with a gap.Comment: 15 pages (RevTex), 21 figures (postscript

MTSEA prevents ligand binding to the human melanocortin-4 receptor by modification of cysteine 130 in transmembrane helix 3

AbstractWe have investigated the effect of the sulfhydryl-reactive reagent, methyl thiosulfonate ethylammonium (MTSEA), on ligand binding to the human melanocortin-4 (MC4) receptor stably expressed in HEK-293 cells. MTSEA inhibited binding of the agonist, 125I-NDPα-MSH, and the antagonist, 125I-SHU9119, in a concentration-dependent manner. Pre-incubation of cells with either the agonist or antagonist protected from subsequent MTSEA inhibition of radioligand binding. Mutation of Cys130 in transmembrane helix 3 to alanine, whilst not affecting ligand binding, led to a complete loss of the inhibitory effect of MTSEA. Since other types of sulfhydryl-reactive reagents had no effect on ligand binding, we conclude that covalent modification of Cys130 by MTSEA disrupts ligand binding by neutralising a close-by negative charge, most likely on Asp126